Torrent Pharmaceuticals, 500420, TORNTPHARM Share Price, Rating, Research, Analysis, Fundamental & Historical Data

Stock Summary

Market Cap(Crs)
Stock P:E
Face Value

108,006.40
62.25
5

Enterprise Value(Crs)
Dividend Yield
Price:Book Value

111,104.78
0.88%
14.77

Chart

Price | P:E | P:BV | EV:EBITDA | MCap:Sales | EPS

Revenue CAGR (%)

10 Years
5 Years
3 Years

8.71
6.21
8.03

EBITDA CAGR (%)

10 Years
5 Years
3 Years

12.67
9.16
6.71

PAT CAGR (%)

10 Years
5 Years
3 Years

8.23
10.08
28.69

P:E (Median)

8 Years
5 Years
3 Years

41.72
53.45
57.85

P:BV (Average)

8 Years
5 Years
3 Years

7.57
8.69
9.47

EV:EBITDA (Average)

8 Years
5 Years
3 Years

19.29
21.38
22.77

Quarterly Results

Consolidated Figures in Rs. Crores /

Standalone

Description Jun 24 Jun 23 Var% Mar 24 Mar 23 Var% Dec 23 Dec 22 Var% Sep 23 Sep 22 Var%
Net Sales 2,438.00 2,121.00 14.95% 2,143.00 1,920.00 11.61% 2,123.00 1,914.00 10.92% 2,146.00 1,928.00 11.31%
Expenses 1,539.00 1,384.00 11.20% 1,427.00 1,342.00 6.33% 1,422.00 1,312.00 8.38% 1,410.00 1,308.00 7.80%
EBITDA 899.00 737.00 21.98% 716.00 578.00 23.88% 701.00 602.00 16.45% 736.00 620.00 18.71%
EBIDTM 36.87% 34.75% 33.41% 30.10% 33.02% 31.45% 34.30% 32.16%
Other Income 21.00 11.00 90.91% 76.00 26.00 192.31% -11.00 16.00 - 15.00 11.00 36.36%
Interest 64.00 90.00 -28.89% 67.00 94.00 -28.72% 69.00 91.00 -24.18% 77.00 62.00 24.19%
Depreciation 189.00 183.00 3.28% 195.00 182.00 7.14% 191.00 185.00 3.24% 192.00 156.00 23.08%
PBT 667.00 475.00 40.42% 530.00 328.00 61.59% 430.00 342.00 25.73% 482.00 413.00 16.71%
Tax 198.00 152.00 30.26% 120.00 109.00 10.09% 133.00 108.00 23.15% 155.00 141.00 9.93%
PAT 469.00 323.00 45.20% 410.00 219.00 87.21% 297.00 234.00 26.92% 327.00 272.00 20.22%
PATM 19.24% 15.23% 19.13% 11.41% 13.99% 12.23% 15.24% 14.11%
EPS 13.86 9.54 45.28% 12.12 6.47 87.33% 8.78 6.91 27.06% 9.66 8.04 20.15%

Description Jun 24 Jun 23 Var% Mar 24 Mar 23 Var% Dec 23 Dec 22 Var% Sep 23 Sep 22 Var%
Net Sales 2,859.00 2,591.00 10.34% 2,745.00 2,491.00 10.20% 2,732.00 2,491.00 9.67% 2,660.00 2,291.00 16.11%
Expenses 1,955.00 1,800.00 8.61% 1,862.00 1,764.00 5.56% 1,863.00 1,767.00 5.43% 1,835.00 1,612.00 13.83%
EBITDA 904.00 791.00 14.29% 883.00 727.00 21.46% 869.00 724.00 20.03% 825.00 679.00 21.50%
EBIDTM 31.62% 30.53% 32.17% 29.19% 31.81% 29.06% 31.02% 29.64%
Other Income 24.00 34.00 -29.41% 31.00 9.00 244.44% -33.00 -10.00 - 26.00 16.00 62.50%
Interest 75.00 103.00 -27.18% 80.00 107.00 -25.23% 80.00 102.00 -21.57% 91.00 69.00 31.88%
Depreciation 197.00 191.00 3.14% 203.00 196.00 3.57% 213.00 193.00 10.36% 201.00 163.00 23.31%
PBT 656.00 531.00 23.54% 631.00 433.00 45.73% 631.00 419.00 50.60% 559.00 463.00 20.73%
Tax 199.00 153.00 30.07% 182.00 146.00 24.66% 188.00 127.00 48.03% 173.00 151.00 14.57%
PAT 457.00 378.00 20.90% 449.00 287.00 56.45% 443.00 292.00 51.71% 386.00 312.00 23.72%
PATM 15.98% 14.59% 16.36% 11.52% 16.22% 11.72% 14.51% 13.62%
EPS 13.50 11.17 20.86% 13.27 8.48 56.49% 13.09 8.63 51.68% 11.40 9.22 23.64%

Annual Results

Consolidated Figures in Rs. Crores /

Standalone

Description TTM Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15
Net Sales 8,850.00 8,532.90 7,695.20 6,742.32 6,450.57 6,168.44 5,762.48 4,244.43 4,551.45 5,419.59 3,475.55 Net Sales Growth 12.27% 10.89% 14.13% 4.52% 4.57% 7.04% 35.77% -6.75% -16.02% 55.93% Cost Of Goods Sold 2,207.00 1,904.52 1,917.47 1,697.36 1,483.37 1,452.32 1,366.31 977.39 1,224.44 1,037.62 949.53 Gross Profit 6,643.00 6,628.38 5,777.73 5,044.96 4,967.20 4,716.12 4,396.17 3,267.04 3,327.01 4,381.97 2,526.02 GP Margin 75.06% 77.68% 75.08% 74.83% 77.00% 76.46% 76.29% 76.97% 73.10% 80.85% 72.68% Total Expenditure 5,798.00 5,643.73 5,230.04 4,641.60 4,258.84 4,251.45 4,149.45 3,337.05 3,424.30 2,778.67 2,640.36 Power & Fuel Cost - 143.43 153.21 140.00 122.04 126.70 131.49 117.86 107.17 91.17 96.57 % Of Sales - 1.68% 1.99% 2.08% 1.89% 2.05% 2.28% 2.78% 2.35% 1.68% 2.78% Employee Cost - 1,450.67 1,251.22 1,097.93 1,097.12 1,061.76 1,014.06 826.07 699.04 572.10 507.41 % Of Sales - 17.00% 16.26% 16.28% 17.01% 17.21% 17.60% 19.46% 15.36% 10.56% 14.60% Manufacturing Exp. - 534.71 518.96 525.94 467.64 510.53 511.80 424.29 483.38 353.59 339.26 % Of Sales - 6.27% 6.74% 7.80% 7.25% 8.28% 8.88% 10.00% 10.62% 6.52% 9.76% General & Admin Exp. - 636.24 543.33 445.93 432.42 428.65 528.34 492.53 397.46 324.98 345.58 % Of Sales - 7.46% 7.06% 6.61% 6.70% 6.95% 9.17% 11.60% 8.73% 6.00% 9.94% Selling & Distn. Exp. - 886.54 788.92 673.65 595.84 596.66 539.39 453.50 388.99 366.53 391.17 % Of Sales - 10.39% 10.25% 9.99% 9.24% 9.67% 9.36% 10.68% 8.55% 6.76% 11.25% Miscellaneous Exp. - 87.62 56.93 60.79 60.41 74.83 58.06 45.41 123.82 32.68 391.17 % Of Sales - 1.03% 0.74% 0.90% 0.94% 1.21% 1.01% 1.07% 2.72% 0.60% 0.31% EBITDA 3,052.00 2,889.17 2,465.16 2,100.72 2,191.73 1,916.99 1,613.03 907.38 1,127.15 2,640.92 835.19 EBITDA Margin 34.49% 33.86% 32.04% 31.16% 33.98% 31.08% 27.99% 21.38% 24.76% 48.73% 24.03% Other Income 101.00 91.49 81.88 204.21 118.34 236.93 381.96 332.31 299.60 293.49 313.83 Interest 277.00 303.04 297.68 236.29 334.12 430.49 480.97 293.68 202.38 179.83 172.72 Depreciation 767.00 761.05 672.34 602.43 609.84 606.66 578.90 383.88 269.36 213.41 180.22 PBT 2,109.00 1,916.57 1,577.02 1,466.21 1,366.11 1,116.77 935.12 562.13 955.01 2,541.17 796.08 Tax 606.00 559.49 525.63 474.76 228.26 178.26 189.70 80.09 100.79 605.36 172.90 Tax Rate 28.73% 29.19% 33.33% 32.38% 16.71% 15.96% 20.29% 14.25% 10.55% 25.78% 21.72% PAT 1,503.00 1,357.08 1,051.39 991.45 1,137.85 938.51 745.42 482.04 854.22 1,742.99 623.18 PAT before Minority Interest 1,503.00 1,357.08 1,051.39 991.45 1,137.85 938.51 745.42 482.04 854.22 1,742.99 623.18 Minority Interest 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 PAT Margin 16.98% 15.90% 13.66% 14.70% 17.64% 15.21% 12.94% 11.36% 18.77% 32.16% 17.93% PAT Growth 43.42% 29.07% 6.05% -12.87% 21.24% 25.90% 54.64% -43.57% -50.99% 179.69% EPS 44.41 40.10 31.07 29.30 33.62 27.73 22.03 14.24 25.24 51.51 18.42

Description TTM Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15
Net Sales 10,996.00 10,727.84 9,620.15 8,508.04 8,004.57 7,939.31 7,672.80 5,949.83 5,815.69 6,666.85 4,653.45 Net Sales Growth 11.48% 11.51% 13.07% 6.29% 0.82% 3.47% 28.96% 2.31% -12.77% 43.27% Cost Of Goods Sold 2,730.00 2,458.95 2,513.20 2,230.75 1,960.12 1,981.79 2,041.26 1,535.17 1,629.66 1,432.13 1,280.96 Gross Profit 8,266.00 8,268.89 7,106.95 6,277.29 6,044.45 5,957.52 5,631.54 4,414.66 4,186.03 5,234.72 3,372.49 GP Margin 75.17% 77.08% 73.88% 73.78% 75.51% 75.04% 73.40% 74.20% 71.98% 78.52% 72.47% Total Expenditure 7,515.00 7,364.25 6,796.18 6,076.77 5,524.49 5,768.95 5,696.31 4,600.58 4,438.42 3,937.05 3,633.29 Power & Fuel Cost - 145.20 155.28 144.19 122.94 128.19 132.46 118.77 107.98 92.59 97.41 % Of Sales - 1.35% 1.61% 1.69% 1.54% 1.61% 1.73% 2.00% 1.86% 1.39% 2.09% Employee Cost - 1,984.40 1,677.69 1,526.45 1,439.62 1,429.04 1,403.79 1,135.25 993.41 842.35 841.81 % Of Sales - 18.50% 17.44% 17.94% 17.98% 18.00% 18.30% 19.08% 17.08% 12.63% 18.09% Manufacturing Exp. - 570.58 570.79 591.13 550.92 544.11 558.84 457.58 502.16 353.45 345.98 % Of Sales - 5.32% 5.93% 6.95% 6.88% 6.85% 7.28% 7.69% 8.63% 5.30% 7.43% General & Admin Exp. - 980.72 775.30 637.65 633.48 801.98 763.90 677.71 578.05 637.92 463.28 % Of Sales - 9.14% 8.06% 7.49% 7.91% 10.10% 9.96% 11.39% 9.94% 9.57% 9.96% Selling & Distn. Exp. - 1,129.68 1,026.99 884.91 742.63 807.39 738.03 641.30 567.70 547.05 574.40 % Of Sales - 10.53% 10.68% 10.40% 9.28% 10.17% 9.62% 10.78% 9.76% 8.21% 12.34% Miscellaneous Exp. - 94.72 76.93 61.69 74.78 76.45 58.03 34.80 59.46 31.56 574.40 % Of Sales - 0.88% 0.80% 0.73% 0.93% 0.96% 0.76% 0.58% 1.02% 0.47% 0.63% EBITDA 3,481.00 3,363.59 2,823.97 2,431.27 2,480.08 2,170.36 1,976.49 1,349.25 1,377.27 2,729.80 1,020.16 EBITDA Margin 31.66% 31.35% 29.35% 28.58% 30.98% 27.34% 25.76% 22.68% 23.68% 40.95% 21.92% Other Income 48.00 61.97 63.22 196.56 56.91 121.30 63.62 298.84 223.30 228.80 285.55 Interest 326.00 353.56 333.44 255.06 352.94 450.71 503.75 308.48 205.56 183.98 175.16 Depreciation 814.00 808.27 706.59 662.16 657.79 654.38 617.69 408.60 306.92 237.55 190.74 PBT 2,477.00 2,263.73 1,847.16 1,710.61 1,526.26 1,186.57 918.67 931.01 1,088.09 2,537.07 939.81 Tax 742.00 695.73 601.93 448.73 274.38 161.85 125.35 252.87 154.51 610.17 188.84 Tax Rate 29.96% 29.58% 32.59% 36.60% 17.98% 13.64% 22.32% 27.16% 14.20% 26.04% 20.09% PAT 1,735.00 1,656.38 1,245.23 777.18 1,251.88 1,024.72 436.28 678.11 933.55 1,733.24 750.94 PAT before Minority Interest 1,735.00 1,656.38 1,245.23 777.18 1,251.88 1,024.72 436.31 678.14 933.58 1,733.27 750.97 Minority Interest 0.00 0.00 0.00 0.00 0.00 0.00 -0.03 -0.03 -0.03 -0.03 -0.03 PAT Margin 15.78% 15.44% 12.94% 9.13% 15.64% 12.91% 5.69% 11.40% 16.05% 26.00% 16.14% PAT Growth 36.72% 33.02% 60.22% -37.92% 22.17% 134.88% -35.66% -27.36% -46.14% 130.81% EPS 51.27 48.95 36.80 22.97 36.99 30.28 12.89 20.04 27.59 51.22 22.19

Results Balance Sheet

Consolidated Figures in Rs. Crores /

Standalone

Description Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15
Shareholder's Funds 6,828.76 6,455.96 6,345.42 6,030.10 5,120.97 5,015.27 4,556.49 4,453.71 3,707.31 2,705.59 Share Capital 169.23 169.23 84.62 84.62 84.62 84.62 84.62 84.62 84.62 84.62 Total Reserves 6,659.53 6,286.73 6,260.80 5,945.48 5,036.35 4,930.65 4,471.87 4,369.09 3,622.69 2,620.97 Non-Current Liabilities 2,559.23 3,006.82 2,383.78 3,116.81 3,308.26 3,924.18 4,275.21 2,442.69 2,079.28 2,478.12 Secured Loans 1,603.78 2,331.78 1,971.60 2,941.07 3,138.43 3,736.88 4,105.31 2,197.48 1,773.65 2,171.60 Unsecured Loans 0.00 0.00 0.00 0.00 1.56 3.11 6.15 11.26 10.62 13.62 Long Term Provisions 282.15 244.54 210.83 193.93 176.72 163.77 149.10 126.34 114.69 97.12 Current Liabilities 2,988.60 3,409.15 2,423.36 2,585.80 3,387.48 3,087.82 2,987.55 1,154.51 1,501.95 1,313.20 Trade Payables 759.76 610.63 624.21 648.05 682.07 582.33 775.72 547.95 665.17 630.23 Other Current Liabilities 827.90 1,450.12 1,278.84 1,420.54 1,822.33 1,694.82 1,091.57 551.16 789.83 413.71 Short Term Borrowings 1,200.00 1,197.77 399.97 410.38 789.31 726.60 1,040.20 0.00 0.00 100.00 Short Term Provisions 200.94 150.63 120.34 106.83 93.77 84.07 80.06 55.40 46.95 169.26 Total Liabilities 12,376.59 12,871.93 11,152.56 11,732.71 11,816.71 12,027.27 11,819.25 8,050.91 7,288.54 6,496.91 Net Block 7,985.92 7,971.85 6,251.25 6,741.24 7,197.50 7,425.15 7,428.53 3,523.49 2,681.39 2,763.50 Gross Block 12,999.81 12,366.86 10,002.35 9,952.74 9,805.61 9,465.64 8,905.10 4,634.19 3,531.56 3,416.05 Accumulated Depreciation 5,013.89 4,395.01 3,751.10 3,211.50 2,608.11 2,040.49 1,476.57 1,110.70 850.17 652.55 Non Current Assets 8,635.53 8,944.85 7,092.51 7,590.83 7,997.45 8,278.32 8,180.11 4,505.33 4,150.74 3,777.96 Capital Work in Progress 226.23 697.93 567.50 588.11 536.41 497.58 447.38 473.07 983.69 627.78 Non Current Investment 322.27 205.12 183.66 174.87 134.87 134.87 149.83 148.41 153.91 150.35 Long Term Loans & Adv. 95.24 68.42 65.30 75.61 100.91 93.35 93.32 237.96 246.50 186.05 Other Non Current Assets 5.87 1.53 24.80 11.00 27.76 127.37 61.05 122.40 85.25 50.28 Current Assets 3,741.06 3,927.08 3,933.40 4,141.88 3,819.26 3,748.95 3,639.14 3,545.58 3,137.80 2,718.95 Current Investments 141.04 156.09 183.98 139.05 0.02 351.35 475.22 787.43 764.24 283.48 Inventories 1,565.59 1,602.23 1,797.11 1,911.74 1,507.76 1,358.30 1,299.40 1,032.29 970.13 781.15 Sundry Debtors 1,571.94 1,729.44 1,541.35 1,544.26 1,508.94 1,356.01 1,108.04 1,018.47 911.50 1,181.32 Cash & Bank 108.76 147.61 69.46 66.42 390.95 237.84 57.09 78.22 82.37 69.68 Other Current Assets 353.73 156.52 232.90 439.17 411.59 445.45 699.39 629.17 409.56 403.32 Short Term Loans & Adv. 122.49 135.19 108.60 41.24 62.74 86.19 182.76 110.06 119.86 103.41 Net Current Assets 752.46 517.93 1,510.04 1,556.08 431.78 661.13 651.59 2,391.07 1,635.85 1,405.75 Total Assets 12,376.59 12,871.93 11,025.91 11,732.71 11,816.71 12,027.27 11,819.25 8,050.91 7,288.54 6,496.91

Description Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15
Shareholder's Funds 6,856.15 6,198.07 5,952.95 5,837.17 4,823.22 4,724.35 4,622.19 4,350.13 3,494.10 2,490.56 Share Capital 169.23 169.23 84.62 84.62 84.62 84.62 84.62 84.62 84.62 84.62 Total Reserves 6,686.92 6,028.84 5,868.33 5,752.55 4,738.60 4,639.73 4,537.57 4,265.51 3,409.48 2,405.94 Non-Current Liabilities 2,224.05 2,822.81 2,238.15 2,924.20 3,299.15 3,861.40 4,142.42 2,303.33 1,994.65 2,504.92 Secured Loans 1,603.78 2,496.22 2,123.22 2,941.07 3,302.29 3,909.81 4,105.31 2,229.57 1,839.46 2,171.60 Unsecured Loans 0.00 0.00 0.00 0.00 1.56 3.11 6.15 11.26 10.62 13.62 Long Term Provisions 444.69 393.06 368.74 369.62 338.34 288.52 286.66 263.04 246.36 207.49 Current Liabilities 5,425.25 5,447.30 4,415.09 4,891.62 5,454.16 5,165.32 5,202.17 2,738.26 3,285.48 2,823.75 Trade Payables 2,089.32 1,678.80 1,674.44 2,066.81 2,048.81 2,096.74 2,048.24 1,749.32 2,260.22 1,827.72 Other Current Liabilities 1,130.15 1,578.41 1,365.10 1,635.36 1,860.80 1,641.26 1,151.68 687.14 822.28 446.15 Short Term Borrowings 1,637.71 1,765.07 923.04 704.40 1,090.85 934.11 1,625.60 0.00 3.32 319.07 Short Term Provisions 568.07 425.02 452.51 485.05 453.70 493.21 376.65 301.80 199.66 230.81 Total Liabilities 14,505.45 14,468.18 12,606.19 13,652.99 13,576.53 13,751.07 13,967.30 9,392.21 8,774.69 7,819.66 Net Block 8,138.11 8,121.45 6,422.65 7,064.63 7,533.12 7,747.71 7,854.68 3,688.44 2,859.08 2,832.66 Gross Block 13,484.57 12,811.62 10,728.19 10,511.53 10,334.13 9,935.43 9,449.48 4,909.80 3,793.53 3,542.93 Accumulated Depreciation 5,346.46 4,690.17 4,305.54 3,446.90 2,801.01 2,187.72 1,594.80 1,221.36 934.45 710.27 Non Current Assets 8,893.97 9,139.00 7,311.54 8,129.77 8,595.61 8,713.53 8,704.89 4,512.74 4,085.66 3,768.25 Capital Work in Progress 360.51 765.40 629.82 889.38 711.93 617.12 646.94 519.49 1,041.58 678.33 Non Current Investment 31.80 42.70 42.33 42.09 2.09 2.09 0.09 0.09 0.09 0.06 Long Term Loans & Adv. 349.34 181.04 166.55 96.84 222.19 150.58 130.96 182.32 99.66 206.92 Other Non Current Assets 14.21 28.41 50.19 36.83 126.28 196.03 72.22 122.40 85.25 50.28 Current Assets 5,611.48 5,313.72 5,164.99 5,523.22 4,980.92 5,037.54 5,262.41 4,879.47 4,689.03 4,051.41 Current Investments 141.04 156.09 183.98 139.05 0.02 351.35 492.27 803.55 779.59 297.59 Inventories 2,279.07 2,229.64 2,462.32 2,681.20 2,148.22 1,935.15 1,966.30 1,559.15 1,357.98 1,067.17 Sundry Debtors 1,844.30 1,943.82 1,632.48 1,523.37 1,649.34 1,435.71 1,253.45 950.89 1,445.09 1,587.26 Cash & Bank 839.04 571.46 403.41 603.50 666.65 816.04 867.23 893.72 647.03 567.36 Other Current Assets 508.03 246.89 331.62 512.69 516.69 499.29 683.16 672.16 459.34 532.03 Short Term Loans & Adv. 180.04 165.82 151.18 63.41 73.48 93.46 95.39 82.62 90.18 109.09 Net Current Assets 186.23 -133.58 749.90 631.60 -473.24 -127.78 60.24 2,141.21 1,403.55 1,227.66 Total Assets 14,505.45 14,452.72 12,476.53 13,652.99 13,576.53 13,751.07 13,967.30 9,392.21 8,774.69 7,819.66

Cash Flow

Consolidated Figures in Rs. Crores /

Standalone

Description Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15
Cash From Operating Activity 2,893.10 2,265.41 2,140.10 1,572.89 1,579.90 1,231.83 929.14 679.38 2,403.00 1,065.16 PBT 1,916.57 1,577.02 1,466.21 1,366.11 1,116.77 935.12 562.13 955.01 2,348.35 796.08 Adjustment 957.61 990.49 827.91 884.80 857.08 820.78 622.51 369.49 480.67 316.60 Changes in Working Capital 343.60 -29.64 86.25 -468.12 -187.25 -315.89 -123.22 -389.94 63.75 -13.74 Cash after chg. in Working capital 3,217.78 2,537.87 2,380.37 1,782.79 1,786.60 1,440.01 1,061.42 934.56 2,892.77 1,098.94 Interest Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Tax Paid -324.68 -272.46 -240.27 -209.90 -206.70 -208.18 -132.28 -255.18 -489.77 -33.78 Other Direct Exp. Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Extra & Other Items 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Cash From Investing Activity -296.07 -2,384.07 -159.70 -316.28 269.43 -373.33 -4,206.99 -532.60 -586.20 -2,098.70 Net Fixed Assets -161.25 -2,494.94 -29.00 -198.83 -378.80 -610.74 -4,245.22 -592.01 -471.42 -2,266.57 Net Investments -102.10 6.43 -53.72 -179.03 351.33 138.83 310.79 -17.69 -484.32 -111.97 Others -32.72 104.44 -76.98 61.58 296.90 98.58 -272.56 77.10 369.54 279.84 Cash from Financing Activity -2,577.57 80.74 -1,977.27 -1,581.20 -1,555.48 -927.58 2,928.72 -131.25 -1,325.82 995.73 Net Cash Inflow / Outflow 19.46 -37.92 3.13 -324.59 293.85 -69.08 -349.13 15.53 490.98 -37.81 Opening Cash & Equivalents 85.40 65.00 61.87 386.46 92.61 512.99 862.12 846.59 353.83 390.97 Closing Cash & Equivalent 104.86 85.40 65.00 61.87 386.46 443.91 512.99 862.12 846.59 353.16

Description Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15
Cash From Operating Activity 3,266.08 2,368.13 1,802.99 2,005.35 1,392.91 1,798.08 894.15 1,008.84 2,742.12 810.20 PBT 2,352.11 1,847.16 1,225.91 1,526.26 1,186.57 561.66 931.01 1,088.09 2,343.44 939.81 Adjustment 993.99 937.24 1,349.95 992.84 876.21 1,418.19 606.92 430.27 552.44 337.96 Changes in Working Capital 418.08 -18.20 -351.85 -338.25 -385.83 99.39 -360.16 -125.21 423.58 -409.38 Cash after chg. in Working capital 3,764.18 2,766.20 2,224.01 2,180.85 1,676.95 2,079.24 1,177.77 1,393.15 3,319.46 868.39 Interest Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Tax Paid -498.10 -398.07 -421.02 -175.50 -284.04 -281.16 -283.62 -384.31 -577.34 -58.19 Other Direct Exp. Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Extra & Other Items 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Cash From Investing Activity -167.90 -2,415.31 -196.63 -449.42 198.61 -241.28 -4,706.95 -786.91 -837.85 -2,162.30 Net Fixed Assets -161.25 -2,494.94 -29.00 -198.83 -378.80 -610.74 -4,245.22 -592.01 -471.42 -2,266.57 Net Investments -102.10 6.43 -53.72 -179.03 351.33 138.83 310.79 -17.69 -484.32 -111.97 Others 95.45 73.20 -113.91 -71.56 226.08 230.63 -772.52 -177.21 117.89 216.24 Cash from Financing Activity -2,779.64 77.36 -1,781.05 -1,650.79 -1,549.04 -1,314.45 3,417.39 -192.91 -1,435.15 1,212.25 Net Cash Inflow / Outflow 318.54 30.18 -174.69 -94.86 42.48 242.35 -395.41 29.02 469.12 -139.85 Opening Cash & Equivalents 508.53 398.40 572.56 661.82 588.76 702.04 1,067.57 1,049.86 612.38 955.05 Closing Cash & Equivalent 835.14 508.53 398.40 572.56 661.82 940.06 702.04 1,067.57 1,049.86 864.95

Financial Ratios

Consolidated /

Standalone

Description Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15
Book Value (Rs.) 201.76 190.75 187.47 178.15 302.59 296.34 269.23 263.16 219.06 159.87 ROA 10.75% 8.75% 8.66% 9.66% 7.87% 6.25% 4.85% 11.14% 25.29% 11.51% ROE 20.43% 16.43% 16.02% 20.41% 18.52% 15.58% 10.70% 20.93% 54.36% 24.95% ROCE 20.96% 18.10% 16.94% 16.30% 14.68% 13.46% 9.89% 18.01% 45.21% 22.40% Fixed Asset Turnover 0.69 0.70 0.69 0.66 0.65 0.63 0.64 1.12 1.57 1.47 Receivable days 69.19 76.09 82.04 85.05 83.57 77.19 90.16 76.69 70.22 130.91 Inventory Days 66.39 79.08 98.61 95.25 83.60 83.26 98.86 79.57 58.76 77.31 Payable days 131.32 117.53 136.79 163.65 52.42 59.32 72.18 69.01 88.12 80.19 Cash Conversion Cycle 4.26 37.63 43.85 16.66 114.75 101.13 116.84 87.25 40.85 128.03 Total Debt/Equity 0.49 0.71 0.53 0.73 1.04 1.12 1.28 0.55 0.61 0.93 Interest Cover 7.32 6.30 7.21 5.09 3.59 2.94 2.91 5.72 14.06 5.61

Description Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15
Book Value (Rs.) 202.57 183.13 175.87 172.45 284.99 279.15 273.11 257.04 206.46 147.16 ROA 11.43% 9.20% 5.92% 9.20% 7.50% 3.15% 5.81% 10.28% 20.89% 11.71% ROE 25.38% 20.50% 13.18% 23.49% 21.47% 9.34% 15.12% 23.80% 57.92% 34.19% ROCE 24.28% 20.32% 14.35% 17.62% 15.28% 9.75% 13.81% 20.36% 45.63% 26.98% Fixed Asset Turnover 1.27 1.39 1.43 1.43 1.48 1.50 1.57 1.35 1.82 1.88 Receivable days 41.38 39.99 37.86 38.92 37.65 33.78 35.74 74.66 82.76 105.19 Inventory Days 49.26 52.47 61.71 59.24 49.84 49.01 57.16 90.90 66.19 81.17 Payable days 279.66 243.50 306.08 383.19 133.47 139.05 150.99 171.27 204.35 176.11 Cash Conversion Cycle -189.03 -151.04 -206.50 -285.04 -45.98 -56.26 -58.09 -5.72 -55.41 10.25 Total Debt/Equity 0.57 0.85 0.68 0.83 1.21 1.28 1.40 0.58 0.67 1.10 Interest Cover 7.65 6.54 5.81 5.32 3.63 2.11 4.02 6.29 13.74 6.37

Top Investors:

investor education and protection fund (iepf)

Annual Reports:

News Update:

Torrent Pharmaceuticals reports 21% rise in Q1 consolidated net profit
24th Jul 2024, 12:14 PM

Total consolidated income of the company increased by 9.83% at Rs 2,883 crore for Q1FY25
Read More
USFDA completes inspections at Torrent Pharmaceuticals’ Gujarat manufacturing facility
13th Jun 2024, 10:23 AM

The inspection was conducted from June 03, 2024 to June 12, 2024
Read More
Torrent Pharmaceuticals enters into patent licensing agreement with Takeda
5th Jun 2024, 16:21 PM

Torrent will market Vonoprazan under its own trademark, Kabvie
Read More
Torrent Pharma - Quarterly Results
24th May 2024, 17:48 PM

Read More

Torrent Pharmaceuticals Ltd.

Pharmaceuticals & Drugs - Global

BSE: 500420 | NSE: TORNTPHARM

Stock Summary

Chart

Price | P:E | P:BV | EV:EBITDA | MCap:Sales | EPS

Revenue CAGR (%)

EBITDA CAGR (%)

PAT CAGR (%)

P:E (Median)

P:BV (Average)

EV:EBITDA (Average)

Quarterly Results

Consolidated Figures in Rs. Crores /

Annual Results

Consolidated Figures in Rs. Crores /

Results Balance Sheet

Consolidated Figures in Rs. Crores /

Cash Flow

Consolidated Figures in Rs. Crores /

Financial Ratios

Consolidated /

Top Investors:

Annual Reports:

News Update:

Torrent Pharmaceuticals Ltd.

Pharmaceuticals & Drugs - Global

BSE: 500420 | NSE: TORNTPHARM

Stock Summary

Shareholding Pattern

Chart

Price | P:E | P:BV | EV:EBITDA | MCap:Sales | EPS

Revenue CAGR (%)

EBITDA CAGR (%)

PAT CAGR (%)

P:E (Median)

P:BV (Average)

EV:EBITDA (Average)

Quarterly Results

Consolidated Figures in Rs. Crores /

Annual Results

Consolidated Figures in Rs. Crores /

Results Balance Sheet

Consolidated Figures in Rs. Crores /

Cash Flow

Consolidated Figures in Rs. Crores /

Financial Ratios

Consolidated /

Top Investors:

Annual Reports:

News Update: